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Passatempo virus was isolated during a zoonotic out-
break. Biologic features and molecular characterization of
hemagglutinin, thymidine kinase, and vaccinia growth fac-
tor genes suggested a vaccinia virus infection, which
strengthens the idea of the reemergence and circulation of
vaccinia virus in Brazil. Molecular polymorphisms indicated
that Passatempo virus is a different isolate.
S
ince 1999, an increasing number of exanthemous out-
breaks affecting dairy cattle and cow milkers in Brazil
have been reported (1–3). These outbreaks were related to
poxvirus infections, which resulted in economic losses to
farmers and affected the health of humans and animals.
Here we report a vaccinia virus (VACV) outbreak that
emerged in March 2003 in the town of Passa-Tempo,
Minas Gerais State, Brazil.
The Study 
The outbreak area is characterized by small rural prop-
erties with diverse crops, pasturelands, and surrounding
fragments of Atlantic Forest. Its climate is tropical, with a
relatively severe dry season, generally from April to
September (4).
All dairy farms were similar, consisting of a main house
with corrals and pasture fields generally with unsophisti-
cated infrastructure. All milking was manually performed
by milkers, typically without strict aseptic measures,
which could have contributed to the spread of the virus
among the herd and milkers. Cows exhibited lesions on
teats and udders that resembled the clinical features
observed during other Brazilian VACV outbreaks (1).
Initial acute lesions were associated with a roseolar erythe-
ma with localized edema that led to the formation of vesi-
cles. The vesicles rapidly progressed to papules and
pustules, which subsequently ruptured and suppurated.
Typically, a thick dark scab followed, but the formation of
large areas of ulceration was also common. The course of
infection lasted from 3 to 4 weeks. Different stages of
lesions were present, ranging from papules to vesicles,
pustules, and crusts (Figure 1). Moreover, because of sec-
ondary infections, some cows had mastitis (Figure 1).
Calves became infected, showing lesions on oral mucosa
and muzzles (Figure 1). Several infected milkers reported
lesions on their hands, which were apparently transmitted
by unprotected contact with sick cattle (Figure 1). In addi-
tion, infected persons reported severe headache, backache,
lymphadenopathy, and high fever. 
For virus isolation, crusts were collected from 5 cows
and 1 calf, macerated, and added to the chorioallantoic
membrane of embryonated eggs (2). The whitish pock-
marks produced on chorioallantoic membranes resembled
VACV pocks, differing from the red hemorrhagic ones
produced by cowpox virus (CPXV) (online Appendix
Figure 1; available at http://www.cdc.gov/ncidod/EID/
vol11no12/05-0773_app1.htm). Blood from affected ani-
mals was collected for neutralization assays (5). Serologic
cross-reactivity of antibodies to VACV–Western Reserve
(WR) strain was detected in all samples, and titers of these
serum samples were >640 U/mL (data not shown). 
Transmission electron microscopy of isolates (6)
showed a morphologic pattern typical of orthopoxviruses
(online Appendix Figure 2; available at http://www.cdc.
gov/ncidod/EID/vol11no12/05-0773_app2.htm). No A-
type inclusion body (ATI) was seen, reinforcing the con-
clusion that this virus was likely not a CPXV, but a VACV.
Viral DNAs were extracted (6) and used as template for ati
gene restriction fragment length polymorphism (RFLP)
analysis (7). The ati RFLP patterns of all isolates were
identical to those of Araçatuba virus (ARAV) (1) and other
VACV strains previously isolated in our laboratory
(unpub. data); they were similar to those of VACV-WR and
completely different from those of CPXV-Brighton Red
(BR) (online Appendix Figure 3; available at http://www.
cdc.gov/ncidod/EID/vol11no12/05-0773_app3.htm).
Since all isolates showed the same ati RFLP pattern, one
was cloned, purified, titrated (1,6), and named Passatempo
virus (PSTV). 
To better identify this etiologic agent, ha, tk, and vgf
genes were amplified by polymerase chain reaction with
Taq polymerase (Promega, Madison, WI, USA) (6,8,9).
Amplicons were cloned into pGEM-T vector (Promega).
Three clones were sequenced 3 times in both orientations
by the dideoxy method, using M13 universal primers and
ET Dynamic Terminator for MegaBACE (GE Healthcare,
Fairfield, CT, USA). The nucleotide (nt) sequences of ha,
tk, and vgf were assembled by using the CAP3 Sequence
Assembling Program (10) and deposited in GenBank
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Brazilunder accession numbers DQ070848, DQ085461, and
DQ085462, respectively. The sequences and inferred
amino acid sequences were aligned with those of
orthopoxviruses by using the ClustalW 1.6 program (11). 
PSTV ha  gene sequence was compared to those of
ARAV, Cantagalo virus (CTGV) (1,2), VACV-WR, CPXV-
BR, VACV Instituto Oswaldo Cruz (VACV-IOC), and
VACV Lister (VACV-LST). VACV-IOC and VACV-LST
are vaccine strains used in the Brazilian smallpox eradica-
tion program (2,6). The PSTV ha gene sequences present-
ed the same 18-nt deletion found in ARAV, CTGV, and
VACV-IOC and shared more similarities to ARAV and
CTGV homologous sequences. Additionally, 8 amino acid
substitutions were unique to PSTV, ARAV, and CTGV.
Since this characteristic was not observed in the vaccine
strains, an independent origin is suggested. Moreover,
PSTV HA differs from that of ARAV and CTGV by 1 and
2 amino acid substitutions, respectively (online Appendix
Figure 4; available at http://www.cdc.gov/ncidod/
EID/vol11no12/05-0773_app4.htm). The percentage of
identity between ha, tk, and vgf nucleotide sequences and
inferred amino acid sequences of PSTV with CPXV-BR
and other VACV strains are presented in the Table. For the
tk gene that is highly conserved among VACV, the PSTV
nucleotide sequence had 100% identity to ARAV, VACV-
LST, and VACV-WR homologous sequences. Addition-
ally, PSTV vgf gene had a 3-nt deletion, corresponding to
nt 7,669–7,671 of VACV-WR, causing the loss of 1
isoleucine in a stretch of 4 found in the ARAV and VACV-
WR VGF sequences (Appendix Figure 4). PSTVVGF also
exhibited 2 amino acid substitutions when compared to
ARAV VGF sequences. 
The alignments were used to construct phylogenetic
trees by the neighbor-joining method using the Tamura Nei
model implemented in MEGA3 (12). Trees were rooted at
midpoint, and 1,000 bootstrap replications were per-
formed. A tk and vgf genes concatenated phylogenetic tree
was constructed by placing PSTV together with VACV
strains (data not shown). Regarding ha sequences, PSTV
was clustered to ARAV and CTGV (Figure 2). 
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Figure 1. Lesions caused by
Passatempo virus infection.
Panels 1 and 2, ulcerative
lesions on cows' teats; 3, mas-
titis caused by bacterial sec-
ondary infection; 4 and 5,
lesion on calves' muzzle and
oral mucosa; 6, lesions of
dairy farm milker. Conclusions
The phylogenetic tree analysis suggested a strong phy-
logenetic relationship between PSTV and other Brazilian
VACV strains. However, the vgf and ha gene analysis of
PSTV, ARAV, and CTGV indicated that genetic hetero-
geneity exists among these viruses, which suggests that the
ha  gene deletion found in PSTV, ARAV, CTGV, and
VACV-IOC could be a signature of New World or
Brazilian VACV strains. 
Additionally, that RFLPanalysis showed a pattern iden-
tical with other Brazilian strains, similar to VACV-WR and
different from CPXV, suggests that a cladogenesis event
may have occurred. This conclusion is feasible considering
that these viruses could be circulating in the wild since
smallpox vaccination or even before, going back to the
colonization of South America, when cattle and other ani-
mals were brought to the New World without quarantine or
inspection. The VACV variants buffalopox and rabbitpox
have originated from VACV subspeciation (13).
That humans were also infected and that these persons
were all milkers, phenomena that had been observed dur-
ing other Brazilian VACV outbreaks, points to an occupa-
tional zoonosis. Although parapoxvirus infection has been
placed in the category of occupational zoonosis, to our
knowledge no other orthopoxviruses have been reported to
cause an occupational hazard. Economic losses are also a
matter of concern. In addition to the reduction in milk pro-
duction, extra veterinary costs are due to the usual occur-
rence of secondary infections on cows’ teats leading to
mastitis. The reduction in milk production is a concern
because Brazil is a major milk exporter. Therefore, the
spread of these viruses could severely impact the country’s
economy. In this regard, the clinical features, widespread
dissemination, and epidemiology of the etiologic agent of
these outbreaks must be understood.
Since 1963, all Brazilian orthopoxvirus isolates have
been characterized as VACVstrains (3,6,14,15). The grow-
ing geographic distribution of these outbreaks (Figure 3)
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 12, December 2005 1937
Figure 2. Consensus bootstrap phylogenetic tree based on the
nucleotide sequence of Orthopoxvirus ha gene. The tree was con-
structed by the neighbor-joining method using the Tamura-Nei
model of nucleotide substitutions implemented in MEGA3. The
tree was midpoint-rooted, 1,000 bootstrap replicates were per-
formed, and values >50% are shown. Nucleotide sequences were
obtained from GenBank under accession numbers: PSTV
(DQ070848), ARAV (AY523994), CTGV (AF229247), VACV-
Wyeth (VVZ99051), VACV-TianTan (U25662), VBH (AY542799),
VACV-WR (AY243312), VACV-Koppe (AF375122), VACV-MVA
(U94848), VACV-IOC (AF229248), VACV-LST (AF375124), VACV-
len (AF375123), VACV-COP (M35027), bfl-3906 (AF375077),
VACV-Malbran (AY146624), RPXV-rev (AF375118), CPXV-GRI90
(CVZ9904), CPXV-BR (AF482758), ECTV-MOS (AF012825),
CMLV-CMS (AY009089), CMLV-M96 (AF438165), VARV-BSH
(L22579), VARV-IND (X69198), MPXV-ZRE (AF380138). (†) indi-
cates Brazilian VACV isolates and (‡) indicates Brazilian vaccine
samples. 
Figure 3. Brazilian states where vaccinia viruses were isolated.
ES, Espírito Santo State: Espírito Santo isolates in 2004 (unpub-
lished); GO, Goiás State: Goiás isolates after 2001 (3); MG, Minas
Gerais State: Belo Horizonte virus in 1993 (15), Minas Gerais iso-
lates after 2001 (3), Passatempo virus in 2003; PA, Pará State:
BeAn 58058 virus in 1963 (6); RJ, Rio de Janeiro State: Cantagalo
virus in 1999 (2); SP , São Paulo State: SPAn232 virus in 1979
(14), Araçatuba virus in 1999 (1), São Paulo isolates after 2001
(3).
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indicates that these viruses may be emerging as zoonotic
pathogens of cattle. This fact is especially important
because a growing human population has no vaccine-
derived immunity to smallpox or other orthopoxviruses.
This situation could create an opportunity for these virus-
es to disseminate in Brazil. In addition, the isolation of
another VACV strain strengthens the hypothesis that
VACV is circulating in the New World and that these
viruses seem to be endemic of this region.
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